EMOR News and Press, Emerald Organic Prods Inc From 04/17/20

  Receives valuation of Alzheimer’s disease blood diagnostic LymPro Test   Retains Donohoe Advisors to assist with Nasdaq CM™ listing process REHOVOT, Israel, SINGAPORE and NEW YORK, NY, April 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd....

REHOVOT, Israel, SINGAPORE and NEW YORK, NY, April 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --  Todos Medical Ltd. (OTCQB: TOMDF) , a commercial  in vitro  diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerati...

  Corona Diagnostics JV adds COVID-19 EUA-submitted point-of-care antibody test kit suppliers   Ongoing pre-commercial clinical trial for TMB-1 and TMB-2 progressing despite COVID-19   Full acquisition of Breakthrough Diagnostics JV pending completion of independent valu...

Holbrook, New York, March 31, 2020 (GLOBE NEWSWIRE) -- Emerald Organic Products Inc. (OTC: EMOR ) ("Emerald" or the "Company") a high growth diversified health science and technology company, today has entered into a definitive agreement to acquire Carie Health Inc. (“Carie ...

  Todos expands rights to include Asian countries and to include PCR test kits   Corona Diagnostics JV with Emerald Organic responsible for commercialization   Dr. Joseph Wee, CEO of Todos Singapore, will lead Asian commercialization effort REHOVOT, Israel and Ne...

Holbrook, NY, March 27, 2020 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. ( OTC: EMOR ) ("Emerald", "Emerald Organic", or "Emerald Organic Products") a diversified health sciences company, today announced it has signed a Plan of Merger Agreement with Bonsa Health , a leading digita...

Todos Medical Ltd. ( OTCQB:TOMDF -14.3% ) and Emerald Organic Products ( OTCPK:EMOR -26.5% ) have formed a joint venture, Corona Diagnostics, LLC, aimed at commercializing the former's Colloidal Gold COVID-19 point-of-care screening test kit, a rapid blood test that detects antibodies to...

HOLBROOK, N.Y. and REHOVOT, Israel, March 24, 2020 /PRNewswire/ -- Emerald Organic Products, Inc. (OTC: EMOR) and Todos Medical Ltd. (OTCQB: TOMDF) today announced the creation of Corona Diagnostics, LLC, a joint venture partnership formed to address the much-needed demand for ...

Merger with Pura Vida Health seen as mutually beneficial for both players in the CBD health and wellness space EMOR’s Pura Vida business plan allows the company to achieve full vertical integration The company promises quality control of CBD product offerings, from seed to shelf ...

  Emerald gains exclusive worldwide development rights to ESS, MANF and PhenoGuard   Amarantus receives Emerald preferred stock valued at a minimum of $66.6 million New York, NY, Jan. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --  Amarantus Bioscience Holdings,...